Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX)
CUSIP: 68235C206
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 32,305,051
- Total 13F shares
- 15,248,594
- Share change
- +147,840
- Total reported value
- $46,050,393
- Price per share
- $3.02
- Number of holders
- 29
- Value change
- +$442,513
- Number of buys
- 15
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 68235C206?
CUSIP 68235C206 identifies IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C206:
Top shareholders of IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
35%
|
11,410,100
|
$34,914,906 | — | 31 Mar 2025 | |
| AWM Investment Company, Inc. |
13D/G
13F
|
Company |
10%
|
2,857,069
|
$9,685,464 | +$5,257,076 | 31 Mar 2025 | |
| Patrick W. Smith |
3/4/5
13D/G
|
10%+ Owner |
10%
from 13D/G
|
3,258,485
|
$6,679,894 | — | 07 Feb 2025 | |
| PURA VIDA INVESTMENTS, LLC |
3/4/5
13F
|
10%+ Owner · Company |
2.9%
from 13F
|
16,591,052
mixed-class rows
|
$3,044,309 | — | 14 Apr 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.82%
|
265,457
|
$812,298 | — | 31 Mar 2025 | |
| BIO-RAD LABORATORIES, INC. |
13D/G
|
— |
9.7%
|
2,764,078
|
$608,097 | $0 | 10 Feb 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
158,907
|
$486,331 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
79,585
|
$243,530 | — | 31 Mar 2025 | |
| WEALTHEDGE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.23%
|
73,971
|
$226,351 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
61,708
|
$188,826 | — | 31 Mar 2025 | |
| John Peter Gutfreund |
3/4/5
|
Former Director |
—
mixed-class rows
|
760,000
mixed-class rows
|
$153,654 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
48,784
|
$149,279 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
44,806
|
$137,106 | — | 31 Mar 2025 | |
| Defender Capital, LLC. |
13F
|
Company |
0.16%
|
44,378
|
$126,921 | — | 31 Mar 2025 | |
| Ronald Asbury Andrews |
3/4/5
|
Former CEO, Director |
—
mixed-class rows
|
633,212
mixed-class rows
|
$125,332 | — | 01 Dec 2022 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.12%
|
39,172
|
$119,000 | — | 31 Mar 2025 | |
| Alfred D. Kingsley |
3/4/5
|
Director |
—
mixed-class rows
|
597,878
mixed-class rows
|
$109,143 | — | 23 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
29,069
|
$88,951 | — | 31 Mar 2025 | |
| Gisela Paulsen |
3/4/5
|
Former President and COO |
—
class O/S missing
|
366,500
|
$78,761 | — | 16 Dec 2022 | |
| Li Yu |
3/4/5
|
VP Cntrllr/Prncpl Acctng Offcr |
—
mixed-class rows
|
41,872
mixed-class rows
|
$76,536 | — | 18 May 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
19,554
|
$59,835 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.05%
|
16,585
|
$51,000 | — | 31 Mar 2025 | |
| Ross Douglas T. |
3/4/5
|
Former CSO |
—
class O/S missing
|
234,114
|
$50,311 | — | 21 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
13,404
|
$41,016 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.03%
|
10,149
|
$31,000 | — | 31 Mar 2025 | |
| Cavan M. Redmond |
3/4/5
|
Director |
—
class O/S missing
|
120,863
|
$25,973 | — | 24 Jun 2022 | |
| Mitchell S. Levine |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
174,580
mixed-class rows
|
$18,713 | — | 15 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,654
|
$8,121 | — | 31 Mar 2025 | |
| Jennifer Levin Carter |
3/4/5
|
Director |
—
mixed-class rows
|
75,500
mixed-class rows
|
$6,554 | — | 15 Aug 2022 | |
| Melinda Griffith |
3/4/5
|
Director |
—
mixed-class rows
|
75,000
mixed-class rows
|
$6,447 | — | 15 Aug 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,263
|
$3,863 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,164
|
$3,562 | — | 31 Mar 2025 | |
| ORG Partners LLC |
13F
|
Company |
0%
|
450
|
$1,350 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
441
|
$1,350 | — | 31 Mar 2025 | |
| Wilmington Savings Fund Society, FSB |
13F
|
Company |
0%
|
250
|
$765 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
208
|
$636 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
185
|
$566 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
168
|
$514 | — | 31 Mar 2025 | |
| Larson Financial Group LLC |
13F
|
Company |
0%
|
125
|
$383 | — | 31 Mar 2025 | |
| Piscataqua Savings Bank |
13F
|
Company |
0%
|
25
|
$76 | — | 31 Mar 2025 | |
| ALBION FINANCIAL GROUP /UT |
13F
|
Company |
0%
|
7
|
$22 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
3
|
$9 | — | 31 Mar 2025 | |
| Anish M. John |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
121,381
|
— | — | 24 Feb 2023 | |
| Padmavathi Sundar |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
87,500
|
— | — | 15 Mar 2022 |
Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) as of Q2 2025
As of 30 Jun 2025,
Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,248,594 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, AWM Investment Company, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., MORGAN STANLEY, Defender Capital, LLC., NORTHERN TRUST CORP, CITADEL ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
29
Q2 2025 holders
29
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.